The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta‐analysis of randomized double‐blind controlled trials
Abstract
Aims The aim of this study was to assess the evidence on the effect of oral magnesium supplementation on glycaemic control in patients with Type 2 diabetes. Methods We searched the electronic databases of medline, embase and the Cochrane Controlled Trials Register up to January 2005. We identified nine randomized double‐blind controlled trials with a total of 370 patients with Type 2 diabetes and of duration 4–16 weeks. The median dose of oral magnesium supplementation was 15 mmol/day (360 mg/day) in the treatment groups. The primary outcome was glycaemic control, as measured by glycated haemoglobin (HbA 1c) or fasting blood glucose levels; the secondary outcomes included body mass index, blood pressure (BP) and lipids. Using a random‐effects model, we calculated the weighted mean differences (WMD) and 95% confidence interval (CI). Results After a median duration of 12 weeks, the weighted mean post‐intervention fasting glucose was significantly lower in the treatment groups compared with the placebo groups [−0.56 mmol/l (95% CI, −1.10 to −0.01); P for heterogeneity = 0.02]. The difference in post‐intervention HbA 1c between magnesium supplementation groups and control groups was not significant [−0.31% (95% CI, −0.81 to 0.19); P for heterogeneity = 0.10]. Neither systolic nor diastolic BP was significantly changed. Magnesium supplementation increased on high‐density lipoprotein (HDL) cholesterol levels [0.08 mmol/l (95% CI, 0.03 to 0.14); P for heterogeneity = 0.36] but had no effect on total cholesterol, low‐density lipoprotein (LDL) cholesterol and triglyceride. Conclusions Oral magnesium supplementation for 4–16 weeks may be effective in reducing plasma fasting glucose levels and raising HDL cholesterol in patients with Type 2 diabetes, although the long‐term benefits and safety of magnesium treatment on glycaemic control remain to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,401
Power and sample size calculations
Dupont, W. D., & Plummer, W. D. (1990) · Controlled Clinical Trials · doi:10.1016/0197-2456(90)90005-m · Cited by 2,092
Systematic Reviews in Health Care: Meta‐Analysis in Context
(2001) · doi:10.1002/9780470693926 · Cited by 1,693
Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X
Barbagallo, M. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(02)00090-0 · Cited by 459
Rodríguez-Morán, M., & Guerrero-Romero, F. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1147 · Cited by 429
Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia
Gerich, J. E. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.11.1306 · Cited by 321
Song, Y., Ridker, P. M., Manson, J. E., Cook, N. R., Buring, J. E., & Liu, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1438 · Cited by 316
Self-citationDietary Magnesium Intake in Relation to Plasma Insulin Levels and Risk of Type 2 Diabetes in Women
Song, Y., Manson, J. E., Buring, J. E., & Liu, S. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.59 · Cited by 304
Self-citationHypertension, Diabetes Mellitus, and Insulin Resistance The Role of Intracellular Magnesium
Paolisso, G. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(96)00342-1 · Cited by 300
Magnesium interrelationships in ischemic heart disease: a review
Seelig, M. S., & Heggtveit, H. A. (1974) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/27.1.59 · Cited by 249
Protective role of magnesium in cardiovascular diseases: A review
Chakraborti, S., Chakraborti, T., Mandal, M., Mandal, A., Das, S., & Ghosh, S. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1019998702946 · Cited by 241
Role of magnesium in the pathogenesis of hypertension
Touyz, R. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(02)00094-8 · Cited by 210
The Effect of Magnesium Supplementation in Increasing Doses on the Control of Type 2 Diabetes
de Lourdes Lima, M., Cruz, T., Pousada, J. C., Rodrigues, L. E., Barbosa, K., & Canguçu, V. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.682 · Cited by 196
Hypomagnesemia and diabetes mellitus. A review of clinical implications
Tosiello, L. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.11.1143 · Cited by 191
Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM Subjects
Paolisso, G., Sgambato, S., Pizza, G., Passariello, N., Varricchio, M., & D'Onofrio, F. (1989) · Diabetes Care · doi:10.2337/diacare.12.4.265 · Cited by 172
Nutrition recommendations and principles for people with diabetes mellitus
(1994) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(94)90211-9 · Cited by 132
Magnesium and Ascorbic Acid Supplementation in Diabetes mellitus
Eriksson, J., & Kohvakka, A. (1995) · Annals of Nutrition and Metabolism · doi:10.1159/000177865 · Cited by 115
Itoh, K., Kawasaki, T., & Nakamura, M. (1997) · British Journal Of Nutrition · doi:10.1079/bjn19970191 · Cited by 110
Paolisso, G., Scheen, A. J., Cozzolino, D., di Maro, G., Varricchio, M., D'Onofrio, F., & Lefebvre, P. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.8200955 · Cited by 104
Hypomagnesemia in Type II Diabetes: Effect of a 3-Month Replacement Therapy
Eibl, N., Kopp, H.-P., Nowak, H. R., Schnack, C., Hopmeier, P., & Schernthaner, G. (1995) · Diabetes Care · doi:10.2337/diacare.18.2.188 · Cited by 95
Clinical Efficacy of Magnesium Supplementation in Patients with Type 2 Diabetes
Yokota, K., Kato, M., Lister, F., Ii, H., Hayakawa, T., Kikuta, T., Kageyama, S., & Tajima, N. (2004) · Journal of the American College of Nutrition · doi:10.1080/07315724.2004.10719390 · Cited by 80
Nutrition Recommendations and Principles for People With Diabetes Mellitus
(1996) · Diabetes Care · doi:10.2337/diacare.19.1.s16 · Cited by 67
Effect of Magnesium Treatment on Glycemic Control and Metabolic Parameters in NIDDM Patients
Gullestad, L. L., Jacobsen, T., & Dolva, L. Ø. (1994) · Diabetes Care · doi:10.2337/diacare.17.5.460 · Cited by 51
Sjögren, A., Florén, C. ‐., & Nilsson, Å. (1988) · PubMed · Cited by 49
Purvis, J. R., Cummings, D. M., Landsman, P. B., Carroll, R. G., Barakat, H. A., Bray, J. T., Whitley, C. B., & Rd, H. (1994) · Archives of Family Medicine · doi:10.1001/archfami.3.6.503 · Cited by 47
de Valk (1998) · doi:10.1002/(sici)1096-9136(199806)15:6<503::aid-dia596>3.0.co;2-m
Cited by
Magnesium in man: implications for health and disease
de Baaij, J. H. F., Hoenderop, J. G. J., & Bindels, R. J. M. (2015) · Physiological Reviews · doi:10.1152/physrev.00012.2014 · Cited by 1,726
de Munter, J. S. L., Hu, F. B., Spiegelman, D., Franz, M., & van Dam, R. M. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040261 · Cited by 734
White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review
Hu, E. A., Pan, A., Malik, V., & Sun, Q. (2012) · BMJ · doi:10.1136/bmj.e1454 · Cited by 631
White rice, brown rice, and risk of type 2 diabetes in US men and women
Sun, Q. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.109 · Cited by 459
Del Gobbo, L. C., Imamura, F., Wu, J. H., de Oliveira Otto, M. C., Chiuve, S. E., & Mozaffarian, D. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.053132 · Cited by 355
Metadata
- Authors
- Song, Y., He, K., Levitan, E. B., Manson, J. E., & Liu, S.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2006-05-31
- Volume
- 23
- Issue
- 10
- Pages
- 1050-1056
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2027208852
- Cited by
- 266
- References
- 29
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.